In consonance with such depletion of leukemic cells, BTLA blockade significantly increased NK cell-mediated cytotoxicity in co-culture experiments employing the CLL-derived cell line MEC-1 as target cells. The gene discussed is BTLA; the disease is B-cell chronic lymphocytic leukemia.